Zinc vs. folic acid for high homocysteine in kidney dialysis
Treatments studied
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests whether zinc supplements can lower high homocysteine levels better than folic acid in people with chronic kidney disease who are on hemodialysis. It aims to find a simple, safe way to help protect your heart and blood vessels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic kidney disease and have been on hemodialysis for at least 3 months.
- Your homocysteine level is higher than 15 micromoles per liter (a blood test measures this).
- You are not currently taking zinc or folic acid supplements.
- You do not have a condition that prevents nutrient absorption (like malabsorption).
- You are not taking certain medications or supplements that could interfere (like vitamin B12, steroids, or some antibiotics).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if the balance of copper and zinc in your blood affects health outcomes for people with end-stage kidney disease on dialysis. It does not test a new drug, but may help doctors understand your condition better.
This trial tests whether controlling homocysteine levels can help people with Parkinson's disease who are taking levodopa. You may qualify if you take at least 300 mg of levodopa per day, are between 40 and 90 years old, and have no major kidney problems or uncontrolled high blood pressure.
This study tests if taking zinc supplements can improve bone health in people with sickle cell disease. It's for those with certain types of sickle cell disease (SS or S-Beta zero thalassemia) who are not on chronic transfusions or zinc supplements.
This trial tests whether taking zinc supplements can improve the outlook for people with a certain type of advanced liver disease that is still stable (no major complications). If you have compensated advanced chronic liver disease and meet the criteria, you might be able to join.
This trial tests whether folic acid can help adults with acute kidney injury (sudden kidney damage) who are in the hospital. If you have this condition and are not already taking folic acid, you may be able to join.
This study is looking at whether fish oil supplements can improve the function of 'good' cholesterol (HDL) in people who are on maintenance hemodialysis. If you are a stable dialysis patient, you may be able to join to help researchers understand how fish oil affects heart and blood vessel health.
Hear when a new Chronic Kidney Disease Requiring Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.